Literature DB >> 2195369

[Intraspinal paraganglioma. Apropos of 3 cases with a review of the literature].

J M Fuentes1, J Benezech, M Marty, J Y Monthieu.   

Abstract

The authors present three cases of paraganglioma located in the cauda equina. In all cases pre-operative diagnosis was neurinoma of the cauda equina and only the histology permitted correct identification. All were intradural extramedullary tumors and in two cases the presenting and dominant symptom was low back pain and sciatica. The remaining third case experimented a paraparesis with urinary and fecal incontinence. The follow-up (range of 4 months-4 years) after total excision was uneventful in two cases and showed in the third case with preoperative paraparesis, some persistent urinary incontinence (follow-up: 3 years) with good motor recovery. The light microscopic features were a Zellballen pattern of cells containing argyrophil granules. Electron microscopy was not performed. The most likely theory regarding the embryogenesis of cauda equina paragangliomas is that they arise from pre-existing paraganglia, possibly of the visceral-autonomic group. The prognosis after complete excision appears to be good. The literature is thoroughly reviewed.

Entities:  

Mesh:

Year:  1990        PMID: 2195369

Source DB:  PubMed          Journal:  Neurochirurgie        ISSN: 0028-3770            Impact factor:   1.553


  3 in total

Review 1.  Cauda equina paraganglioma: a review.

Authors:  George C Miliaras; Athanassios P Kyritsis; Konstantinos S Polyzoidis
Journal:  J Neurooncol       Date:  2003-11       Impact factor: 4.130

2.  Paraganglioma of the cauda equina: magnetic resonance imaging.

Authors:  M Boukobza; J F Foncin; D Dowling-Carter
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

3.  Cauda equina paraganglioma with subsequent intracranial and intraspinal metastases.

Authors:  P H Roche; D Figarella-Branger; J Regis; J C Peragut
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.